PO-0824: Dose effects by interfractional variability of tumor and OAR on the example of prostate-Ca-patients. (April 2018) - Splinter, M.; Bostel, T.; Häring, P.; Lang, C.; Huber, P.; Meyerhof, E.; Debus, J.; Jäkel, O.; Nicolay, N.H.